nature.com search

Loading Filters

Showing 1–39 of 39 results

Loading Filters

Correspondence | 8 July 2004
Response to “Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion?” by Peggs et al
- F A Ayuk
- , A R Zander
- & N Kröger
Leukemia 18 , 1542–1543

Rights & permissionsfor article Response to “Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion?” by Peggs <i>et al</i> . Opens in a new window.
11 February 2008
Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques
- M Lioznov
- , A Badbaran
- , B Fehse
- , U Bacher
- , A R Zander
- & N M Kröger
Bone Marrow Transplantation 41 , 913–916

Rights & permissionsfor article Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques . Opens in a new window.
28 February 2011
Circulating CD34⁺ cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT
- H Alchalby
- , M Lioznov
- , U Fritzsche-Friedland
- , A Badbaran
- , T Zabelina
- , U Bacher
- , T Stübig
- , F A Ayuk
- , A R Zander
- & N Kröger
Bone Marrow Transplantation 47 , 143–145

Rights & permissionsfor article Circulating CD34<sup>+</sup> cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT . Opens in a new window.
10 November 2008
Outcome of allo-SCT for chronic myelomonocytic leukemia
- S Ocheni
- , N Kröger
- , T Zabelina
- , A R Zander
- & U Bacher
Bone Marrow Transplantation 43 , 659–661

Rights & permissionsfor article Outcome of allo-SCT for chronic myelomonocytic leukemia . Opens in a new window.
3 September 2012
Evaluation of BM cytomorphology after allo-SCT in patients with MDS
- M Christopeit
- , S Ocheni
- , T Haferlach
- , K Miersch
- , T Zabelina
- , E Klyuchnikov
- , M Binder
- , F Ayuk
- , P Schafhausen
- , A R Zander
- , C Bokemeyer
- , N Kröger
- & U Bacher
Bone Marrow Transplantation 48 , 465–466

Rights & permissionsfor article Evaluation of BM cytomorphology after allo-SCT in patients with MDS . Opens in a new window.
Correspondence | 11 December 2003
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma
- F Ayuk
- , A Shimoni
- , A Nagler
- , R Schwerdtfeger
- , M Kiehl
- , H G Sayer
- , T Zabelina
- , A R Zander
- & N Kröger
Leukemia 18 , 659–662

Rights & permissionsfor article Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma . Opens in a new window.
Research | 23 January 2017
Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT
- P Esser
- , K Kuba
- , A Mehnert
- , A Schwinn
- , L Schirmer
- , F Schulz-Kindermann
- , M Kruse
- , U Koch
- , A R Zander
- , N Kröger
- , G Schilling
- , H Götze
- & A Scherwath
Bone Marrow Transplantation 52 , 753–758

Rights & permissionsfor article Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT . Opens in a new window.
Research | 11 May 2009
Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors
- O W Neth
- , U Bacher
- , P Das
- , T Zabelina
- , H Kabisch
- , N Kroeger
- , F Ayuk
- , M Lioznov
- , O Waschke
- , B Fehse
- , R Thiébaut
- , R M Haston
- , N Klein
- & A R Zander
Bone Marrow Transplantation 45 , 13–19

Rights & permissionsfor article Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors . Opens in a new window.
Research | 14 November 2005
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation
- J Dahlke
- , N Kröger
- , T Zabelina
- , F Ayuk
- , N Fehse
- , C Wolschke
- , O Waschke
- , H Schieder
- , H Renges
- , W Krüger
- , A Kruell
- , A Hinke
- , R Erttmann
- , H Kabisch
- & A R Zander
Bone Marrow Transplantation 37 , 155–163

Rights & permissionsfor article Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation . Opens in a new window.
9 August 1999
Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking
- M Hildinger
- , A Schilz
- , H-G Eckert
- , W Bohn
- , B Fehse
- , A R Zander
- , W Ostertag
- & C Baum
Gene Therapy 6 , 1222–1230

Rights & permissionsfor article Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking . Opens in a new window.
Research | 6 August 2012
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
- N Kröger
- , T Zabelina
- , E Klyuchnikov
- , M Kropff
- , K-H Pflüger
- , A Burchert
- , T Stübig
- , C Wolschke
- , F Ayuk
- , Y Hildebrandt
- , U Bacher
- , A Badbaran
- , G Schilling
- , T Hansen
- , D Atanackovic
- & A R Zander
Bone Marrow Transplantation 48 , 403–407

Rights & permissionsfor article Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients . Opens in a new window.
Research | 19 January 2009
Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation
- J Rischer
- , A Scherwath
- , A R Zander
- , U Koch
- & F Schulz-Kindermann
Bone Marrow Transplantation 44 , 121–128

Rights & permissionsfor article Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation . Opens in a new window.
Research | 25 October 2010
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
- K Hübel
- , M M Fresen
- , H Salwender
- , N Basara
- , R Beier
- , S Theurich
- , M Christopeit
- , C Bogner
- , O Galm
- , R Hartwig
- , F Heits
- , F Lordick
- , W Rösler
- , D Wehler
- , A R Zander
- , M H Albert
- , S Dressler
- , M Ebinger
- , N Frickhofen
- , B Hertenstein
- , M Kiehl
- , S Liebler
- , M von Lilienfeld-Toal
- , E Weidmann
- , C Weigelt
- , F Lange
- & N Kröger
Bone Marrow Transplantation 46 , 1045–1052

Rights & permissionsfor article Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program . Opens in a new window.
Research | 8 November 2002
A novel ‘sort-suicide’ fusion gene vector for T cell manipulation
- B Fehse
- , O S Kustikova
- , Z Li
- , A Wahlers
- , W Bohn
- , W R Beyer
- , D Chalmers
- , P Tiberghien
- , K Kühlcke
- , A R Zander
- & C Baum
Gene Therapy 9 , 1633–1638

Rights & permissionsfor article A novel ‘sort-suicide’ fusion gene vector for T cell manipulation . Opens in a new window.
Research | 3 September 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
- H Einsele
- , M Bamberg
- , W Budach
- , H Schmidberger
- , C F Hess
- , B Wörmann
- , C Meisner
- , C Straka
- , H Hebart
- , L Trümper
- , N Kröger
- , A R Zander
- , S Hegewisch-Becker
- , D K Hossfeld
- , H Schmidt
- , P Müller
- , G Schlimok
- , B Hertenstein
- , D Peest
- , B Metzner
- , N Frickhofen
- , L Kanz
- & W I Bensinger
Bone Marrow Transplantation 32 , 593–599

Rights & permissionsfor article A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma . Opens in a new window.
Research | 6 October 1999
Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements
- F A Ayuk
- , Z Li
- , K Kühlcke
- , C Lindemann
- , U M Schade
- , H-G Eckert
- , A R Zander
- & B Fehse
Gene Therapy 6 , 1788–1792

Rights & permissionsfor article Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements . Opens in a new window.
Research | 19 June 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
- F A Giordano
- , B Fehse
- , A Hotz-Wagenblatt
- , S Jonnakuty
- , C del Val
- , J-U Appelt
- , K Z Nagy
- , K Kuehlcke
- , S Naundorf
- , A R Zander
- , W J Zeller
- , A D Ho
- , S Fruehauf
- & S Laufs
Bone Marrow Transplantation 38 , 229–235

Rights & permissionsfor article Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions . Opens in a new window.
Research | 1 February 1981
Human myeloid leukaemic cell interactions in vitro with normal myeloid colonies
- G Spitzer
- , D S Verma
- , M Beran
- , A R Zander
- , K A Dicke
- , K B McCredie
- , S Siegel
- & S Tindle
British Journal of Cancer 43 , 149–156

Rights & permissionsfor article Human myeloid leukaemic cell interactions <i>in vitro</i> with normal myeloid colonies . Opens in a new window.
Research | 5 August 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)
- A R Zander
- , N Kröger
- , M Schleuning
- , J Finke
- , T Zabelina
- , D Beelen
- , R Schwerdtfeger
- , H Baurmann
- , M Bornhäuser
- , G Ehninger
- , A A Fauser
- , M Kiehl
- , R Trenschel
- , H D Ottinger
- , H Bertz
- , J Berger
- , H-J Kolb
- & U W Schaefer
Bone Marrow Transplantation 32 , 355–361

Rights & permissionsfor article ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) . Opens in a new window.
Research | 22 February 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia
- C Craddock
- , M Labopin
- , S Pillai
- , J Finke
- , D Bunjes
- , H Greinix
- , G Ehninger
- , N-K Steckel
- , A R Zander
- , R Schwerdtfeger
- , S Buchholz
- , H-J Kolb
- , L Volin
- , A Fauser
- , E Polge
- , C Schmid
- , M Mohty
- & V Rocha
Leukemia 25 , 808–813

Rights & permissionsfor article Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia . Opens in a new window.
Research | 11 January 2010
Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
- H Alchalby
- , A Badbaran
- , O Bock
- , B Fehse
- , U Bacher
- , A R Zander
- & N Kröger
Bone Marrow Transplantation 45 , 1404–1407

Rights & permissionsfor article Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT . Opens in a new window.
Research | 6 July 2009
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44⁺) and T (HLA-DR⁺) cells
- M Lioznov
- , J El-Cheikh Jr
- , F Hoffmann
- , Y Hildebrandt
- , F Ayuk
- , C Wolschke
- , D Atanackovic
- , G Schilling
- , A Badbaran
- , U Bacher
- , B Fehse
- , A R Zander
- , D Blaise
- , M Mohty
- & N Kröger
Bone Marrow Transplantation 45 , 349–353

Rights & permissionsfor article Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44<sup>+</sup>) and T (HLA-DR<sup>+</sup>) cells . Opens in a new window.
Comments and Opinion | 18 February 2003
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias
- A Shimoni
- , N Kröger
- , A R Zander
- , J M Rowe
- , I Hardan
- , A Avigdor
- , M Yeshurun
- , I Ben-Bassat
- & A Nagler
Leukemia 17 , 290–297

Rights & permissionsfor article Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias . Opens in a new window.
7 June 2011
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
- N Kröger
- , T Zabelina
- , J Berger
- , H Duske
- , E Klyuchnikov
- , T Binder
- , T Stübig
- , Y Hilde-brandt
- , D Atanackovic
- , H Alchalby
- , F Ayuk
- , A R Zander
- , U Bacher
- & T Eiermann
Leukemia 25 , 1657–1661

Rights & permissionsfor article Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma . Opens in a new window.
4 November 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning
- A Shimoni
- , N Kröger
- , T Zabelina
- , F Ayuk
- , I Hardan
- , M Yeshurun
- , N Shem-Tov
- , A Avigdor
- , I Ben-Bassat
- , A R Zander
- & A Nagler
Leukemia 19 , 7–12

Rights & permissionsfor article Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning . Opens in a new window.
Research | 2 June 2008
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT
- S Ocheni
- , N Kroeger
- , T Zabelina
- , I Sobottka
- , F Ayuk
- , C Wolschke
- , A Muth
- , H Lellek
- , L Petersen
- , R Erttmann
- , H Kabisch
- , A R Zander
- & U Bacher
Bone Marrow Transplantation 42 , 181–186

Rights & permissionsfor article EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT . Opens in a new window.
Research | 7 April 2008
Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM
- M Lioznov
- , C Dellbrügger
- , A Sputtek
- , B Fehse
- , N Kröger
- & A R Zander
Bone Marrow Transplantation 42 , 121–128

Rights & permissionsfor article Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM . Opens in a new window.
5 September 2000 | Open
Expression of human milk fat globulin proteins in cells of haemopoietic origin
- W Krüger
- , R Lohner
- , R Jung
- , N Kröger
- & A R Zander
British Journal of Cancer 83 , 874–879

Rights & permissionsfor article Expression of human milk fat globulin proteins in cells of haemopoietic origin . Opens in a new window.
Research | 30 April 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AML
- M Christopeit
- , K Miersch
- , E Klyuchnikov
- , T Haferlach
- , M Binder
- , T Zabelina
- , F Ayuk
- , P Schafhausen
- , A R Zander
- , C Bokemeyer
- , N Kröger
- & U Bacher
Bone Marrow Transplantation 47 , 1538–1544

Rights & permissionsfor article Evaluation of BM cytomorphology after allo-SCT in patients with AML . Opens in a new window.
Research | 12 December 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
- J Casper
- , J Holowiecki
- , R Trenschel
- , H Wandt
- , K Schaefer-Eckart
- , T Ruutu
- , L Volin
- , H Einsele
- , G Stuhler
- , L Uharek
- , I Blau
- , M Bornhaeuser
- , A R Zander
- , K Larsson
- , M Markiewicz
- , S Giebel
- , T Kruzel
- , H A Mylius
- , J Baumgart
- , U Pichlmeier
- , M Freund
- & D W Beelen
Bone Marrow Transplantation 47 , 1171–1177

Rights & permissionsfor article Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning . Opens in a new window.
Research | 14 March 2005
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
- M V Lioznov
- , P Freiberger
- , N Kröger
- , A R Zander
- & B Fehse
Bone Marrow Transplantation 35 , 909–914

Rights & permissionsfor article Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants . Opens in a new window.
Research | 1 December 2003
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients
- N Kröger
- , L Damon
- , A R Zander
- , H Wandt
- , G Derigs
- , P Ferrante
- , T Demirer
- & G Rosti
Bone Marrow Transplantation 32 , 1153–1157

Rights & permissionsfor article Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients . Opens in a new window.
Research | 6 April 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
- P Chevallier
- , M Labopin
- , A Nagler
- , P Ljungman
- , L F Verdonck
- , L Volin
- , A R Zander
- , J Finke
- , G Socie
- , C Cordonnier
- , J-L Harousseau
- , M Mohty
- & V Rocha
Bone Marrow Transplantation 44 , 589–594

Rights & permissionsfor article Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT . Opens in a new window.
Research | 6 May 2003
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation
- M Weber
- , N Kröger
- , F Langer
- , A Hansen
- , T Zabelina
- , B Eifrig
- , D K Hossfeld
- & A R Zander
Bone Marrow Transplantation 31 , 817–822

Rights & permissionsfor article Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation . Opens in a new window.
Research | 31 October 2005
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up
- A A Oyekunle
- , N Kröger
- , T Zabelina
- , F Ayuk
- , H Schieder
- , H Renges
- , N Fehse
- , O Waschke
- , B Fehse
- , H Kabisch
- & A R Zander
Bone Marrow Transplantation 37 , 45–50

Rights & permissionsfor article Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up . Opens in a new window.
Research | 10 January 2014 | Open
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines
- B C Valdez
- , A R Zander
- , G Song
- , D Murray
- , Y Nieto
- , Y Li
- , R E Champlin
- & B S Andersson
Blood Cancer Journal 4 , e171–e171

Rights & permissionsfor article Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines . Opens in a new window.
Research | 9 April 2007
Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies
- F Schulz-Kindermann
- , A Mehnert
- , A Scherwath
- , L Schirmer
- , B Schleimer
- , A R Zander
- & U Koch
Bone Marrow Transplantation 39 , 789–799

Rights & permissionsfor article Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies . Opens in a new window.
13 April 2009
Interactive diagnostics in the indication to allogeneic SCT in AML
- U Bacher
- , C Haferlach
- , S Schnittger
- , W Kern
- , N Kroeger
- , A R Zander
- & T Haferlach
Bone Marrow Transplantation 43 , 745–756

Rights & permissionsfor article Interactive diagnostics in the indication to allogeneic SCT in AML . Opens in a new window.
30 June 2008
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
- U Bacher
- , A R Zander
- , T Haferlach
- , S Schnittger
- , B Fehse
- & N Kröger
Bone Marrow Transplantation 42 , 145–157

Rights & permissionsfor article Minimal residual disease diagnostics in myeloid malignancies in the post transplant period . Opens in a new window.

Quick links